Melanie Lianne Engelfriet

Image of Melanie Lianne Engelfriet
Norwegian version of this page
Room 2116
Username
Visiting address Blindernveien 31 0371 Oslo
Postal address Postboks 1066 Blindern 0316 Oslo
Other affiliations Faculty of Mathematics and Natural Sciences (Student)

Academic interests

I started my PhD in September 2019 in the research groups of Rafal Ciosk and Pål Falnes. During my PhD, I will characterize novel molecular mechanisms that regulate translation with an emphasis on the role of methyltransferases in translation. I am using the nematode C. elegans as an experimental model to elucidate how methylation of translation factors affects biological processes under various conditions. 

Education

2019 - now   PhD at the department of Biosciences, University of Oslo, Norway. 

2016 - 2018  Master in Molecular Biology at the department of Biosciences, University of Oslo, Norway. 

2012 - 2016  Bachelor in Biology and Medical Laboratory Research at the department of Science and Technology, University of Applied Sciences Leiden, The Netherlands. 

Teaching

BIOS2900 - Molecular Biology (TA)

BIOS4010 - Methods in Molecular Biology and Biochemistry I (TA)

Awards

  • 2016: VSBfonds Scholarship. VSBfonds, NUFFIC, The Netherlands. Scholarship for Dutch students doing research abroad. 
  • 2015: KNCVTBC Grant. KNCV Tuberculosis Foundation, The Netherlands. Grant for Master and PhD students involved with scientific research on tuberculosis. 

 

 

Publications

  • Engelfriet, Melanie Lianne; Malecki, Jedrzej Mieczyslaw; Forsberg, Frida; Falnes, Pål & Ciosk, Rafal (2023). Characterization of the biochemical activity and tumor-promoting role of the dual protein methyltransferase METL-13/METTL13 in Caenorhabditis elegans. PLOS ONE. ISSN 1932-6203. 18(6), p. 1–16. doi: 10.1371/journal.pone.0287558. Full text in Research Archive
  • van der Schoot, Johan M. S.; Fenneman, Felix L.; Valente, Michael; Dolen, Yusuf; Hagemans, Iris M. & Becker, Anouk M. D. [Show all 21 contributors for this article] (2019). Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering. Science Advances. ISSN 2375-2548. 5(8). doi: 10.1126/sciadv.aaw1822.

View all works in Cristin

Published Nov. 21, 2019 9:20 AM - Last modified May 7, 2020 1:19 PM

Research groups